Chidamide Plus DICE Regimen for Patients With Relapse or Refractory B-cell Non-Hodgkin's Lymphoma (NHL)
Clinical trial NCT03105596 · UNKNOWN
Trial details
- NCT number
- NCT03105596
- Sponsor
- Peking University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-11
- Primary completion
- 2018-09-30
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.